Zydus Lifesciences Limited Losartan Export Data — India (DGFT 2022–2026)

Name: Zydus Lifesciences Limited Losartan Export Records India — #1 Exporter, 562 Shipments, $28.1M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Losartan

India Pharmaceutical Trade Intelligence

$301.0M506 Suppliers141 CountriesHS 30049073

ExportsIndia → UNITED STATES44.6%India → PHILIPPINES10.6%

ImportsISRAEL → India$24.8M SPAIN → India$4.5M

#1 Supplier: ZYDUS LIFESCIENCES #1 Buyer: EVERSANA LIFE

Zydus Lifesciences Limited — Losartan Exporter #1 | $28.1M Trade Value | TransData Nexus | TransData Nexus

Zydus Lifesciences Limited — Losartan Exporter Profile

Indian Pharmaceutical Exporter · #1 for Losartan · $28.1M export value · DGFT Verified

Zydus Lifesciences Limited is the #1 Indian exporter of Losartan with $28.1M in export value and 562 verified shipments. Zydus Lifesciences Limited holds a 9.3% market share in Losartan exports across 15 countries. The company exports 81 pharmaceutical products worth $346.3M across 25 therapeutic categories.

Zydus Lifesciences Limited — Losartan Export Profile: Buyers & Destinations

Zydus Lifesciences Limited Losartan export treemap — buyers and destination countries | TransData Nexus

Where Does Zydus Lifesciences Limited Export Losartan?

Country	Value	Shipments	Share
UNITED STATES	$11.4M	358	68.1%
SRI LANKA	$2.4M	75	14.6%
THAILAND	$1.0M	33	6.0%
KENYA	$666.6K	18	4.0%

Who Are the Top Buyers of Losartan from Zydus Lifesciences Limited?

Buyer	Country	Value	Orders
EVERSANA LIFE SCIENCE SERVICES	UNITED STATES	$10.1M	324
SUNSHINE HEALTHCARE LANKA LIMITED	SRI LANKA	$2.2M	66
ABACUS PHARMA (AFRICA) LTD	UGANDA	$753.0K	19
PRIORITY HEALTHCARE DISTRIBUTION DB	UNITED STATES	$565.7K	15
PHARMALAND (1982) CO. LTD	THAILAND	$562.8K	18
PRIORITY HEALTHCARE DISTRIBUTION	UNITED STATES	$550.0K	11
PHARMALAND (1982) CO.LTD	THAILAND	$324.3K	9
STATE PHARMACEUTICALS	SRI LANKA	$197.6K	8
ABACUS PHARMA (AFRICA) LIMITED	UGANDA	$191.9K	4
EVERSANA LIFE SCIENCE SERVICES,	UNITED STATES	$142.7K	7

Zydus Lifesciences Limited supplies Losartan to 37 buyers globally. The largest buyer is EVERSANA LIFE SCIENCE SERVICES (UNITED STATES), followed by SUNSHINE HEALTHCARE LANKA LIMITED (SRI LANKA) and ABACUS PHARMA (AFRICA) LTD (UGANDA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Losartan Formulations Does Zydus Lifesciences Limited Export?

Product Description / Formulation	Value	Shipments
PHARMA MEDICINE FOR HUMAN USE-LOSARTAN	$1.2M	27
LOSARTAN POTASSIUM 100 MG 1X90T	$628.1K	16
LOSARTAN POTASSIUM 50 MG 1X90T	$541.7K	12
LOSARTAN POTASSIUM 100 MG 1X90T (OTHER DETAILS AS PER INV & P.LIST)NOS	$303.6K	12
LOSARTAN POTASSIUM 100 MG 1X90T DIST. NDC - 68382-137-16 MFG. NDC - 65841-731-16(AS PER INVOICE. & P.LIST)	$300.0K	6
PHARMACEUTICAL MEDICINE FOR HUMAN USE -LOSARTAN POTASSIUM 100 MG 1X90T	$299.4K	10
LOSARTAN POTASSIUM 50 MG 1X90T (OTHER DETAILS AS PER INV & P.LIST)	$296.9K	15
LOSARTAN POTASSIUM 100 MG 1X90T (OTHER DETAILS AS PER INV & P.LIST)	$285.6K	9
PHARMA : LOSARTAN POTASSIUM 50 MG (LOSAR	$250.0K	5
PHARMA : LOSARTAN POTASSIUM 100 MG (LOSA	$241.6K	6

Zydus Lifesciences Limited exports 267 distinct Losartan formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PHARMA MEDICINE FOR HUMAN USE-LOSARTAN with 27 shipments worth $1.2M.

How Does Zydus Lifesciences Limited Compare to Nearest Losartan Exporters?

Exporters ranked immediately above and below #1 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	ZYDUS LIFESCIENCES LIMITED ★	$28.1M	562	15	$50.0K
2	MICRO LABS LIMITED	$20.5M	676	26	$30.3K
4	AUROBINDO PHARMA LTD	$13.0M	423	11	$30.6K

Zydus Lifesciences Limited ranks #1 among 506 Indian Losartan exporters. Average shipment value of $50.0K compared to the market average of $283.3K. The closest competitors by value are MICRO LABS LIMITED and AUROBINDO PHARMA LTD.

Which Indian Ports Ship Losartan Exports?

Port	Shipments	% Share
SAHAR AIR	1,020	9.4%
NHAVA SHEVA SEA (INNSA1)	946	8.7%
SAHAR AIR CARGO ACC (INBOM4)	886	8.1%
DELHI AIR CARGO ACC (INDEL4)	702	6.4%
DELHI AIR	672	6.2%
JNPT/ NHAVA SHEVA SEA	549	5.0%
MUNDRA SEA	491	4.5%
HYDERABAD ICD	384	3.5%

Geopolitical & Trade Policy Impact on Zydus Lifesciences Limited's Losartan Exports

Zydus Lifesciences's export operations are influenced by various geopolitical factors. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, increasing shipping costs and transit times for Indian exporters. This situation necessitates strategic logistics planning to mitigate potential delays and cost escalations.

Conversely, U.S.-China trade tensions have opened opportunities for Indian pharmaceutical companies like Zydus to capture a larger share of the U.S. market, as American importers seek alternative suppliers. Zydus's recent FDA approvals, including Niacin ER Tablets and Leuprolide Acetate injection, position the company to capitalize on this shift. (ainvest.com)

In the European Union, compliance with the Falsified Medicines Directive (FMD) is crucial for market access. Zydus's proactive measures to align with these regulations enhance its credibility and competitiveness in the EU market. However, the ongoing Israel-Iran conflict poses risks to Middle East trade routes, potentially affecting Zydus's operations in that region.

Zydus Lifesciences Limited — Regulatory Compliance & Quality Standards

Maintaining stringent quality standards is paramount for Zydus Lifesciences. In October 2025, the company received an Establishment Inspection Report (EIR) with a Voluntary Action Indicated (VAI) status from the U.S. FDA for its Baddi manufacturing facility, indicating compliance with regulatory standards. (bajajbroking.in) Similarly, the Ahmedabad SEZ-II facility received a clean USFDA report in November 2025, further affirming the company's commitment to quality. (bajajbroking.in)

These regulatory approvals are critical, as non-compliance can lead to import bans and reputational damage. Zydus's adherence to Good Manufacturing Practices (GMP) and proactive engagement with regulatory bodies underscore its dedication to maintaining high-quality standards across its operations.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Losartan shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Zydus Lifesciences Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 562 individual customs records matching Zydus Lifesciences Limited exporting Losartan, covering 267 formulations to 16 countries via 37 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 141+ countries, 1,415+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Losartan

Losartan

Zydus Lifesciences Limited — Losartan Exporter Profile

Zydus Lifesciences Limited — Losartan Export Profile: Buyers & Destinations

Where Does Zydus Lifesciences Limited Export Losartan?

Who Are the Top Buyers of Losartan from Zydus Lifesciences Limited?

What Is India's Total Losartan Export Value and How Much Does Zydus Lifesciences Limited Contribute?

What Is the Average Shipment Value for Zydus Lifesciences Limited's Losartan Exports?

How Does Zydus Lifesciences Limited Compare to Other Indian Losartan Exporters?

What Losartan Formulations Does Zydus Lifesciences Limited Export?

Regulatory Requirements: Exporting Losartan to Key Markets

United States — FDA

How Does Zydus Lifesciences Limited Compare to Nearest Losartan Exporters?

Which Indian Ports Ship Losartan Exports?

What Other Cardiovascular Products Does Zydus Lifesciences Limited Export?

Losartan — Export Intelligence Video

Geopolitical & Trade Policy Impact on Zydus Lifesciences Limited's Losartan Exports

Zydus Lifesciences Limited — Regulatory Compliance & Quality Standards

About Zydus Lifesciences Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Losartan Export Data from Zydus Lifesciences Limited

Losartan Stats

Company Overview

Top Products by Zydus Lifesciences Limited

Related Analysis

Need Detailed Export Data?

Data Source